Drug Database
IN
indometacin plaster
✓ ApprovedKowa · PTGS1 · Small Molecule
What is indometacin plaster?
indometacin plaster is a small molecule developed by Kowa. It is approved for therapeutic indications via transdermal.
Drug Profile
| Company | Kowa |
| Drug Class | Small Molecule |
| Molecular Target | PTGS1, PTGS2 |
| Route | Transdermal |
| Status | Approved |
Sources: ClinicalTrials.gov, Kowa
Mechanism of Action
Molecular Targets
indometacin plaster acts on 2 molecular targets:
| PTGS1 | prostaglandin-endoperoxide synthase 1 (COX3, PCOX1) |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
indometacin plaster is developed for 2 unique indications across 2 therapeutic areas.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Gastrointestinal disorders | Abdominal pain | ✓ Approved |
| Skin and subcutaneous tissue disorders | Pruritus | ✓ Approved |
Related Research Articles
Unable to load articles right now.